Position in ABUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$36,158,097
+$6,339,347 QoQ
Shares Held
7,532,937
+13.7% QoQ
Ownership
3.81%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#6
of 175 holders
Holding Since
Dec 2022
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rubric Capital Management LP holds $1,431,610,576 across 20 Biotechnology names. ABUS ranks #12 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
8,271,577 | $216,880,748 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
6,000,000 | $212,340,000 | |
| 3 | ZYME |
Zymeworks Inc.
|
7,000,000 | $182,980,000 | |
| 4 | NRIX |
Nurix Therapeutics, Inc.
|
7,227,778 | $175,345,894 | |
| 5 | MGTX |
MeiraGTx Holdings plc
|
9,100,000 | $122,941,000 | |
| 6 | ARDX |
Ardelyx, Inc.
|
16,202,700 | $82,633,770 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
9,339,414 | $78,170,895 | |
| 8 | MNKD |
Mannkind Corp
|
18,000,000 | $76,680,000 |
All Filings in ABUS
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,158,097 | 7,532,937 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $29,818,750 | 6,626,389 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,577,558 | 1,575,376 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,152,207 | 1,575,376 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,867,911 | 1,575,376 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,867,004 | 1,681,090 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,497,164 | 1,681,090 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,472,196 | 1,681,090 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,194,568 | 1,681,090 | Shares | Sole | 2024-08-13 | |
| 2023-06-30 | $7,810,466 | 3,395,855 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $12,711,068 | 4,195,072 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,076,434 | 3,466,281 | Shares | Sole | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||